Alumis ALMS
NASDAQ ALMS
$6.31 -0.24 (-3.66%)
As of: Nov 10, 2026 · 3:00 PM EST

Alumis (ALMS) Receivables (2025 - 2026)

Updated

Alumis (ALMS) reported Receivables of $100,000 for Q4 2025, unchanged from the prior quarter.

Analysis

Alumis (ALMS) Receivables (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 18.99 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 13.51 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 14.33 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 5.01 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 14.19 Bn
10 Alumis 830.27 Mn -881.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 2.70 Mn
API Access

Alumis Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ALMS&period=max&api_key=YOUR_API_KEY